Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules.
Lymphoid nodules are a normal component of the mucosa of the rectum, but little is known about their function and whether they contribute to the host immune response in malignancy. In rectal cancer specimens from patients with local (n=18), regional (n=12) and distant (n=10) disease, we quantified T cell (CD3, CD25) and dendritic cell (CD1a, CD83) levels at the tumour margin as well as within tumour-associated lymphoid nodules. In normal tissue CD3+, but not CD25+, T cells are concentrated at high levels within lymphoid nodules, with significantly fewer cells found in surrounding normal mucosa (P=0.001). Mature (CD83), but not immature (CD1a), dendritic cells in normal tissue are also found clustered almost exclusively within lymphoid nodules (P=<0.0001). In rectal tumours, both CD3+ T cells (P=0.004) and CD83+ dendritic cells (P=0.0001) are also localized preferentially within tumour-associated lymphoid nodules. However, when comparing tumour specimens to normal rectal tissue, the average density of CD3+ T cells (P=0.0005) and CD83+ dendritic cells (P=0.0006) in tumour-associated lymphoid nodules was significantly less than that seen in lymphoid nodules in normal mucosa. Interestingly, regardless of where quantified, T cell and dendritic cell levels did not depend upon the stage of disease. Increased CD3+ T cell infiltration of tumour-associated lymphoid nodules predicted improved survival, independent of stage (P=0.05). Other T cell (CD25) markers and different levels of CD1a+ or CD83+ dendritic cells did not predict survival. Tumour-associated lymphoid nodules, enriched in dendritic cells and T cells, may be an important site for antigen presentation and increased T cell infiltration may be a marker for improved survival.
McMullen
T P W
TP
Division of General Surgery, University of Alberta, Edmonton, Alberta, Canada. todd.mcmullen@ualberta.net
Lai
R
R
Dabbagh
L
L
Wallace
T M
TM
de Gara
C J
CJ
D000230:Adenocarcinoma / Q000276:immunology* / Q000401:mortality / Q000473:pathology / Q000556:secondary; D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D018949:Antigens, CD1 / Q000032:analysis; D017252:CD3 Complex / Q000032:analysis; D003713:Dendritic Cells / Q000737:chemistry / Q000276:immunology / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D016130:Immunophenotyping; D053645:Interleukin-2 Receptor alpha Subunit / Q000032:analysis; D007413:Intestinal Mucosa / Q000276:immunology* / Q000473:pathology; D053208:Kaplan-Meier Estimate; D016246:Lymphocytes, Tumor-Infiltrating / Q000737:chemistry / Q000276:immunology*; D008221:Lymphoid Tissue / Q000473:pathology*; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000276:immunology*; D011379:Prognosis; D012004:Rectal Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000737:chemistry / Q000276:immunology*; D000097802:CD83 Antigen
D015703:Antigens, CD; D018949:Antigens, CD1; D017252:CD3 Complex; D007136:Immunoglobulins; D053645:Interleukin-2 Receptor alpha Subunit; D008562:Membrane Glycoproteins; D000097802:CD83 Antigen; C419393:CD1a antigen; C508017:IL2RA protein, human
Br J Surg. 2001 Sep;88(9):1221-7
11531871
Science. 2006 Sep 29;313(5795):1960-4
17008531
Eur J Cancer. 2003 Oct;39(15):2214-22
14522381
Mod Pathol. 2005 May;18(5):681-5
15578077
Mod Pathol. 2005 Sep;18(9):1223-31
15933757
J Pathol. 2002 Jan;196(1):37-43
11748640
Jpn J Clin Oncol. 2004 Feb;34(2):90-8
15067103
Lab Invest. 2004 Apr;84(4):493-501
14968119
J Anat. 1986 Dec;149:189-94
3693106
Cancer Metastasis Rev. 2007 Dec;26(3-4):373-400
17717638
J Immunother. 2001 Mar-Apr;24(2):130-7
11265770
Oncol Rep. 2003 Mar-Apr;10(2):309-13
12579264
J Immunol. 2001 Apr 15;166(8):4958-67
11290774
J Clin Pathol. 1986 Jun;39(6):585-9
3722412
World J Gastroenterol. 2006 Dec 7;12(45):7233-8
17143936
Br J Cancer. 2004 Nov 1;91(9):1711-7
15494715
Cancer Metastasis Rev. 1984;3(1):53-74
6370420
Nature. 1998 Mar 19;392(6673):245-52
9521319
Clin Cancer Res. 2005 Apr 1;11(7):2576-82
15814636
Histopathology. 1986 Mar;10(3):267-83
3486153
Cancer. 1989 Feb 1;63(3):496-503
2912528
Cancer Immunol Immunother. 2004 Nov;53(11):978-86
15197496
Hum Pathol. 2004 Jul;35(7):808-16
15257543
J Clin Invest. 2007 May;117(5):1195-203
17476349
J Immunol. 1998 Apr 1;160(7):3081-5
9531260
Clin Cancer Res. 2006 May 15;12(10):3064-9
16707603
N Engl J Med. 2005 Dec 22;353(25):2654-66
16371631
Cancer Res. 2009 Oct 15;69(20):7895-8
19808962
J Transl Med. 2007 Nov 29;5:62
18047662
Ann Surg. 2006 Dec;244(6):986-92; discussion 992-3
17122624
Clin Anat. 2006 Mar;19(2):164-70
16444704
Cancer Res. 1998 Aug 15;58(16):3491-4
9721846
Semin Oncol. 2007 Jun;34(3):241-9
17560986
Int J Cancer. 2005 Oct 10;116(6):949-56
15856455
Mol Immunol. 2005 Feb;42(4):541-6
15607811
Cancer. 1999 Apr 15;85(8):1670-6
10223559
Front Biosci. 2007 May 01;12:4050-60
17485358